NCT02621151 2025-10-07Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the BladderNYU Langone HealthPhase 2 Active not recruiting60 enrolled 11 charts